NS
Naveed Sattar
University of Glasgow
Research areas: Medicine · Endocrinology, Diabetes and Metabolism · Diabetes, Cardiovascular Risks, and Lipoproteins · Diabetes Treatment and Management · Lipoproteins and Cardiovascular Health
0000-0002-1604-2593
Employment
-
University of Glasgow Professor of Metabolic Medicine2005 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (356)
- Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease Save
- A metabolomic signature of weight-loss and its associations with BMI-linked diseases: A post-hoc analysis of two intervention trials and a mendelian randomisation study Save
- Anthropometric, Muscle Function, Physical Activity, Inflammatory and Dietary Characteristics Associated With Fasting Glucose and Insulin Resistance in Rural and Urban Malawian Adults: A Cross‐Sectional Study Save
- Macrotroponin Complexes and Risk of Cardiovascular Events Save
- Cardiovascular Risk in SELECT-Eligible MI Patients With Overweight or Obesity Save
- Performance of prediction models for incident heart failure and heart failure hospitalization in individuals with type 2 diabetes: a systematic review and meta-analysis Save
- Obesity management: a foundational cardiovascular health priority Save
- Subcutaneous adipocyte glucocorticoid-responsive transcripts after modest weight gain in South Asian and White European men: an exploratory longitudinal study Save
- Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND Save
- Age of Type 1 Diabetes Onset and Dementia Risk: A Swedish Nationwide, Register‐Based Cohort Study Save
- Association Between Blood Hemoglobin Concentration and Mortality by Age and Sex Save
- Multiorgan protective therapy for CKM syndrome: the role of GLP-1-based therapies and SGLT2 inhibitors Save
- Obesity medicines as disruptive innovation Save
- Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE‐O Trial Save
- Associations between adult obesity and mid-life weight change patterns with cardiometabolic health in early old age: Evidence from the 1958 British birth cohort Save
- Achieving the triple endpoint of body weight reduction thresholds, systolic blood pressure reduction ≥5 mmHg and non-HDL cholesterol <130 mg/dL with tirzepatide in people with obesity: A post hoc analysis from the SURMOUNT trials Save
- Levothyroxine treatment response of cardiometabolic biomarkers in older adults with subclinical hypothyroidism Save
- Predicted 10-year cardiovascular disease risk reduction with tirzepatide use over 3 years for primary prevention of cardiovascular disease in obesity Save
- A consensus diabetes core dataset for research using NHS data: outputs from a Diabetes Data Science Catalyst workshop Save
- Achieving at Least 15% Weight Loss Within 2 Years of Type 2 Diabetes Diagnosis Is Associated With Lower Risks of Macrovascular and Microvascular Complications: A U.K. Cohort Study Save